| CAS Number | 21462-39-5 (HCl) / 24729-96-2 (Phosphate) |
|---|---|
| Molecular Formula | C18H33ClN2O5S · HCl (HCl) / C18H34ClN2O8PS (Phosphate) |
| Molecular Weight | 461.44 (HCl) / 504.96 (Phosphate) |
| Pharmacopoeia | BP/USP/CEP/EP/CPV |
| Packaging | 25 KG/DRUM |
Clindamycin is a semi-synthetic lincosamide antibiotic derived from lincomycin. It has superior oral absorption and broader activity compared to its parent compound, effective against most Gram-positive bacteria and anaerobes.
Clindamycin inhibits bacterial protein synthesis at the 50S ribosomal subunit. Clindamycin HCl is used for oral formulations, while Clindamycin Phosphate is a water-soluble prodrug for injectable and topical preparations.
| Purity | As per USP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |